Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1.

Tuberous sclerosis complex (TSC) is a genetic disorder linked to mutations of either the TSC1 or TSC2 gene, which encode proteins that form a complex to negatively regulate mammalian target of rapamycin complex 1 (mTORC1). Clinically, a small percentage of TSC patients develop severe infantile polycystic kidney disease (PKD), which is believed to be caused by deletion of the contiguous TSC2 and PKD1 genes on human chromosome 16. Recent studies have implicated the TSC/mTORC1 signaling pathway in PKD, but how dysfunction of the TSC/mTORC1 pathway induces PKD is not clear. We report a PKD mouse model created by knocking out Tsc1 in a subset of renal tubular cells. Extensive renal cyst formation in these mice is accompanied by broadly elevated mTORC1 activity in both cell autonomous and non-cell autonomous compartments. Furthermore, cyst development requires mTORC1 activation, as low dosage of rapamycin administration effectively blocks cyst formation. Interestingly, disruption of Pten, an upstream regulator of TSC1/TSC2, in the same cells, does not lead to PKD seemingly due to limited activation of mTORC1, suggesting that PTEN may not be a major upstream regulator of TSC/mTORC1 during early postnatal kidney development.

[1]  P. Pandolfi,et al.  Polycystin-1 Regulates Extracellular Signal-Regulated Kinase-Dependent Phosphorylation of Tuberin To Control Cell Size through mTOR and Its Downstream Effectors S6K and 4EBP1 , 2009, Molecular and Cellular Biology.

[2]  Wei Zhang,et al.  Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice , 2009, The Journal of Neuroscience.

[3]  E. Henske,et al.  The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway , 2008, Human molecular genetics.

[4]  Oliver Greiner,et al.  An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice , 2008, Nature Medicine.

[5]  H. Moch,et al.  pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation , 2008, The EMBO journal.

[6]  P. Igarashi,et al.  Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. , 2008, Human molecular genetics.

[7]  G. Germino,et al.  A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1 , 2007, Nature Medicine.

[8]  F. Jensen,et al.  A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival , 2007, The Journal of Neuroscience.

[9]  E. Halpern,et al.  Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. , 2006, Kidney international.

[10]  Wei Zhang,et al.  Pten Regulates Neuronal Arborization and Social Interaction in Mice , 2006, Neuron.

[11]  A. Novick,et al.  The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Baker,et al.  Neuron‐specific enolase‐cre mouse line with cre activity in specific neuronal populations , 2006, Genesis.

[13]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[14]  D. Griffiths,et al.  A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma. , 2005, Human molecular genetics.

[15]  J. Blenis,et al.  mTOR, translational control and human disease. , 2005, Seminars in cell & developmental biology.

[16]  C. Martyn,et al.  An epidemiological study of renal pathology in tuberous sclerosis complex , 2004, BJU international.

[17]  J. Cook,et al.  Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development. , 2003, The American journal of pathology.

[18]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[19]  Tian Xu,et al.  Akt regulates growth by directly phosphorylating Tsc2 , 2002, Nature Cell Biology.

[20]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[21]  J. Blenis,et al.  Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. , 2002, Molecular cell.

[22]  Hongbing Zhang,et al.  A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. , 2002, Human molecular genetics.

[23]  Tetsuo Noda,et al.  A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Sasaki,et al.  T cell-specific loss of Pten leads to defects in central and peripheral tolerance. , 2001, Immunity.

[25]  G. Landes,et al.  Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. , 2001, Molecular cell.

[26]  Shankar Srinivas,et al.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus , 2001, BMC Developmental Biology.

[27]  E. Haan,et al.  Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. , 1997, American journal of human genetics.

[28]  J. Sampson,et al.  A cross sectional study of renal involvement in tuberous sclerosis. , 1996, Journal of medical genetics.

[29]  J. Hughes,et al.  Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease — a contiguous gene syndrome , 1994, Nature Genetics.

[30]  A. Knudson,et al.  Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Osborne,et al.  Tuberous sclerosis and polycystic kidney disease. , 1993, BMJ.

[32]  E. Garin,et al.  Early presentation of tuberous sclerosis as bilateral renal cysts. , 1993, The Journal of urology.

[33]  D. Johnson,et al.  The cystic renal lesion in tuberous sclerosis. , 1980, The Journal of pediatrics.

[34]  D. Albers,et al.  Tuberous sclerosis presenting as polycystic kidneys and seizures in an infant. , 1970, The Journal of pediatrics.

[35]  Kun-Liang Guan,et al.  Dysregulation of the TSC-mTOR pathway in human disease , 2004, Nature Genetics.

[36]  P. Igarashi,et al.  Genetics and Pathogenesis of Polycystic Kidney Disease , 2002 .

[37]  Philippe Soriano.  Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[38]  Y. Kubo,et al.  A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer , 1995, Nature Genetics.